Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Nauta

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Biochemical Pharmacology|April 1, 1977
Reduction of 2,6-dichlorophenol indophenol by bovine methemoglobin reductase in the presence of a number of non-steroidal anti-inflammatory compoundsC N Verboom, J de Vries, L van Bree, et al.
Biochemical Pharmacology|March 15, 1978
Effects of 2-aryl-1,3-indandiones on the reduction of 2,6-dichlorophenol indophenol by methemoglobin reductaseJ de Vries, C N Verboom, L van Bree, et al.
Diabetes Care|July 21, 2012
Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008Sjoerd T Nauta, Jaap W Deckers, K Martijn Akkerhuis, et al.
Circulation|September 26, 2012
Sex-related trends in mortality in hospitalized men and women after myocardial infarction between 1985 and 2008: equal benefit for women and menSjoerd T Nauta, Jaap W Deckers, Ron T van Domburg, et al.
International Journal of Cardiology|April 3, 2012
Age-dependent care and long-term (20 year) mortality of 14,434 myocardial infarction patients: changes from 1985 to 2008Sjoerd T Nauta, Jaap W Deckers, K Martijn Akkerhuis, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1979
Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administrationJ de Vries, C N Verboom, E J Groot, et al.
Biochemical Pharmacology|June 15, 1976
Inhibition of beta-glucuronidase by 2-diarylmethyl-1,3-indandionesG van den Berg, M L de Winter, W A de Boer, et al.
International Journal of Cardiology|September 14, 2014
Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?L T Burgers, S T Nauta, J W Deckers, et al.
Kidney International|March 15, 2013
Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention eraSjoerd T Nauta, Ron T van Domburg, Rutger-Jan Nuis, et al.
International Journal of Cardiology|February 21, 2013
Weekend versus weekday mortality in ST-segment elevation acute myocardial infarction patients between 1985 and 2008Sanne M Snelder, Sjoerd T Nauta, K Martijn Akkerhuis, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Biochemical Pharmacology|April 1, 1977
Reduction of 2,6-dichlorophenol indophenol by bovine methemoglobin reductase in the presence of a number of non-steroidal anti-inflammatory compoundsC N Verboom, J de Vries, L van Bree, et al.
Biochemical Pharmacology|March 15, 1978
Effects of 2-aryl-1,3-indandiones on the reduction of 2,6-dichlorophenol indophenol by methemoglobin reductaseJ de Vries, C N Verboom, L van Bree, et al.
Diabetes Care|July 21, 2012
Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008Sjoerd T Nauta, Jaap W Deckers, K Martijn Akkerhuis, et al.
Circulation|September 26, 2012
Sex-related trends in mortality in hospitalized men and women after myocardial infarction between 1985 and 2008: equal benefit for women and menSjoerd T Nauta, Jaap W Deckers, Ron T van Domburg, et al.
International Journal of Cardiology|April 3, 2012
Age-dependent care and long-term (20 year) mortality of 14,434 myocardial infarction patients: changes from 1985 to 2008Sjoerd T Nauta, Jaap W Deckers, K Martijn Akkerhuis, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1979
Pharmacokinetics of 2-phenyl-1,3-indandione in the rat after i.v. and oral administrationJ de Vries, C N Verboom, E J Groot, et al.
Biochemical Pharmacology|June 15, 1976
Inhibition of beta-glucuronidase by 2-diarylmethyl-1,3-indandionesG van den Berg, M L de Winter, W A de Boer, et al.
International Journal of Cardiology|September 14, 2014
Is it cost-effective to use a test to decide which individuals with an intermediate cardiovascular disease risk would benefit from statin treatment?L T Burgers, S T Nauta, J W Deckers, et al.
Kidney International|March 15, 2013
Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention eraSjoerd T Nauta, Ron T van Domburg, Rutger-Jan Nuis, et al.
International Journal of Cardiology|February 21, 2013
Weekend versus weekday mortality in ST-segment elevation acute myocardial infarction patients between 1985 and 2008Sanne M Snelder, Sjoerd T Nauta, K Martijn Akkerhuis, et al.
Pageof 5